News

Filter

Current filters:

GenentechTarceva

1 to 9 of 97556 results

RegeneRx links with G-treeBNT to develop RGN-259 in the USA

29-01-2015

US biotech firm RegeneRx Biopharmaceuticals has entered into agreements with South Korea-based G-treeBNT…

BiotechnologyG-treeBNTLicensingMergers & AcquisitionsOphthalmicsRegeneRxRGN-259USA

TxCell receives latest 1 million-euro milestone payment in OvaSave license agreement

TxCell receives latest 1 million-euro milestone payment in OvaSave license agreement

29-01-2015

French biotech company TxCell has received the latest 1 million-euro milestone payment ($1.13 million)…

BiotechnologyGastro-intestinalsLicensingOvaSaveResearchTxCell

Study shows Photocure's Hexvix significantly improves overall survival in bladder cancer

Study shows Photocure's Hexvix significantly improves overall survival in bladder cancer

29-01-2015

Photodynamic technology specialist Photocure has published data on a retrospective study showing Hexvix…

BiotechnologyHexvixOncologyPhotocureResearch

Long-term solutions needed for kidney disease, says EAF report

Long-term solutions needed for kidney disease, says EAF report

29-01-2015

Greater education and support for non-specialist health care professionals is needed to ensure the accurate…

EuropeHealthcareNephrology and HepatologyOtsuka PharmaceuticalPharmaceutical

Applied Molecular Transport inks research and license agreement with Janssen on IBS therapy

Applied Molecular Transport inks research and license agreement with Janssen on IBS therapy

28-01-2015

Biopharma company Applied Molecular Transport has entered into a research collaboration and license agreement…

Applied Molecular TransportGastro-intestinalsJanssenJohnson & JohnsonLicensingPharmaceutical

US House Energy & Commerce Committee releases 21 Century Cures Act discussion draft

US House Energy & Commerce Committee releases 21 Century Cures Act discussion draft

28-01-2015

The promised January 2015 release of a discussion draft of legislation to implement the 21st Century…

PatentsPharmaceuticalPoliticsResearchUSA

AnaMar to focus on severe inflammation and fibrosis

28-01-2015

Swedish privately-held biopharma company AnaMar says it will focus pipeline development on severe inflammation…

AnaMarBiotechnologyInflammatory diseasesLicensingResearchRespiratory and Pulmonary

Ferring appoints Pascal Danglas and Per Falk to senior positions

Ferring appoints Pascal Danglas and Per Falk to senior positions

28-01-2015

Switzerland-headquartered Ferring Pharmaceuticals has appointed Pascal Danglas as executive vice president…

BoardroomFerring PharmaceuticalsPascal DanglasPharmaceuticalSwitzerland

1 to 9 of 97556 results

Back to top